7-128028018-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022143.5(LRRC4):c.*661G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 152,726 control chromosomes in the GnomAD database, including 1,187 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 1186 hom., cov: 32)
Exomes 𝑓: 0.10 ( 1 hom. )
Consequence
LRRC4
NM_022143.5 3_prime_UTR
NM_022143.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.00400
Publications
8 publications found
Genes affected
LRRC4 (HGNC:15586): (leucine rich repeat containing 4) Predicted to be involved in modulation of chemical synaptic transmission and synapse organization. Predicted to act upstream of or within synapse organization. Predicted to be located in neuron spine and postsynaptic membrane. Predicted to be active in Schaffer collateral - CA1 synapse; glutamatergic synapse; and plasma membrane. Predicted to be integral component of postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2022]
SND1 (HGNC:30646): (staphylococcal nuclease and tudor domain containing 1) This gene encodes a transcriptional co-activator that interacts with the acidic domain of Epstein-Barr virus nuclear antigen 2 (EBNA 2), a transcriptional activator that is required for B-lymphocyte transformation. Other transcription factors that interact with this protein are signal transducers and activators of transcription, STATs. This protein is also thought to be essential for normal cell growth. A similar protein in mammals and other organisms is a component of the RNA-induced silencing complex (RISC). [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRRC4 | NM_022143.5 | c.*661G>A | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000249363.4 | NP_071426.1 | ||
| SND1 | NM_014390.4 | c.1779+36962C>T | intron_variant | Intron 16 of 23 | ENST00000354725.8 | NP_055205.2 | ||
| LRRC4 | XM_011516461.4 | c.*661G>A | 3_prime_UTR_variant | Exon 3 of 3 | XP_011514763.1 | |||
| LRRC4 | XM_047420695.1 | c.*661G>A | 3_prime_UTR_variant | Exon 3 of 3 | XP_047276651.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.110 AC: 16660AN: 152142Hom.: 1181 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16660
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.103 AC: 48AN: 466Hom.: 1 Cov.: 0 AF XY: 0.109 AC XY: 30AN XY: 276 show subpopulations
GnomAD4 exome
AF:
AC:
48
AN:
466
Hom.:
Cov.:
0
AF XY:
AC XY:
30
AN XY:
276
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
42
AN:
418
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
5
AN:
38
Other (OTH)
AF:
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.110 AC: 16684AN: 152260Hom.: 1186 Cov.: 32 AF XY: 0.113 AC XY: 8407AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
16684
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
8407
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
1945
AN:
41540
American (AMR)
AF:
AC:
3270
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
538
AN:
3472
East Asian (EAS)
AF:
AC:
403
AN:
5190
South Asian (SAS)
AF:
AC:
855
AN:
4826
European-Finnish (FIN)
AF:
AC:
1164
AN:
10608
Middle Eastern (MID)
AF:
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8154
AN:
68010
Other (OTH)
AF:
AC:
239
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
764
1528
2293
3057
3821
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
516
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.